Three Singapore Blue-Chip Dividend Stocks Approaching 52-Week Peaks
When a stock reaches its 52-week high, it's easy to believe the most significant gains have already been realized.
However, for investors focused on income, the share price is just one part of the equation.
A more critical question is whether the fundamental dividends can continue their growth from this point.
Three Singapore blue-chip stocks are currently trading near their 52-week highs, yet the dividend stories for each are distinctly different.
Here is a detailed examination.
$Singapore Exchange(S68.SI)$
Singapore Exchange, the sole operator of the local bourse, continues to demonstrate the strength of its wide-moat business.
Net revenue for the first half of FY2026 increased 7.6% year-on-year to S$695.4 million, driven by a 16.2% surge in its Equities – Cash division as average daily trading volumes rose nearly 20%.
Although net profit appeared relatively flat at S$342.7 million, dividend investors should look beyond this headline figure.
A one-off impairment of S$15.0 million related to Scientific Beta affected the results; on an adjusted basis, net profit actually grew a much healthier 11.6%.
More importantly for long-term compounding, SGX generated S$363.7 million in operating cash flow.
This comfortably covers its quarterly dividend of S$0.110 per share.
Management's commitment to increasing the dividend by S$0.0025 every quarter through FY2028 provides a level of forward visibility that is uncommon among blue-chip companies.
At a price of S$21.17, the yield of 2.1% is modest, but it represents a path for steady and predictable growth.
$Oversea-Chinese Banking Corporation Limited(O39.SI)$
Singapore's second-largest bank by assets reported record total income of S$14.6 billion for FY2025, a 1% increase from the previous year.
What is impressive is how the bank managed a declining interest rate environment by leveraging its wealth management arm, where fees increased by 33%.
Net interest income fell 6% to S$9.2 billion due to compressed margins, but healthy loan growth provided a necessary cushion.
However, the dividend requires careful analysis.
The total FY2025 payout of S$0.99 includes a S$0.16 special dividend; excluding that, the recurring ordinary dividend is S$0.83.
At a share price of S$22.81, the headline yield is 4.3%, but the ordinary yield is closer to 3.6%.
If OCBC's "Next Frontier" strategy continues to capture Asian wealth flows – which now contribute 38% of total income – there is potential for this payout to grow even as interest rates normalize.
Investors should base their expectations on the recurring income, not the one-time bonuses.
$Seatrium Limited(5E2.SI)$
Seatrium completes the trio with a very different investment proposition.
Revenue for FY2025 surged 24.3% year-on-year to S$11.5 billion, and net profit more than doubled to S$323.6 million.
On the surface, doubling its dividend to S$0.03 per share appears to show strong momentum.
But as dividend investors, it is essential to examine the underlying financials.
Free cash flow only just turned positive at S$19.7 million – a very slim margin for a company of this size.
With a capital-intensive order book of S$17.8 billion, cash demands will remain high through 2033.
At a price of S$2.48, the trailing yield is just 1.2%.
This is a recovery story, not a primary income investment.
While the S$32 billion pipeline indicates strong operational momentum, dividend investors should moderate their expectations until free cash flow demonstrates it can consistently support a higher payout.
$(5E2.SI)$ $(O39.SI)$ $(S68.SI)$Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

